SCHEMBL4515723

SCHEMBL4515723

COc1c(Cl)cc(OCc2ccccc2)cc1C=NO

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.52
GAA P10253 3/20 0.52
HPGD P15428 2/20 0.52
RAB9A P51151 5/20 0.50
NPC1 O15118 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
NFKB1 P19838 3/20 0.50
NFKB2 Q00653 3/20 0.50
RELA Q04206 3/20 0.50
LMNA P02545 3/20 0.49
MAOB P27338 5/20 0.47
CYP1A2 P05177 4/20 0.46
CYP3A4 P08684 4/20 0.46
CYP2C19 P33261 4/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HSP90AA1 P07900 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4515720 1.00 MAPT (0.52) MAPTGAAHPGDRAB9ANPC1
SCHEMBL5762307 0.87 RAB9A (0.46) MAPTGAAHPGDRAB9ANPC1
SCHEMBL4497582 0.83 TUBB1 (0.50) HPGDRAB9ANPC1SMN1; SMN2LMNA
SCHEMBL5761016 0.79 MAPT (0.49) MAPTGAAHPGDRAB9ANPC1
SCHEMBL4511160 0.77 ALDH1A1 (0.44) MAPTGAAHPGDRAB9ANPC1
SCHEMBL4511158 0.77 ALDH1A1 (0.44) MAPTGAAHPGDRAB9ANPC1
SCHEMBL16990042 0.75 MAPT (0.51) MAPTGAAHPGDRAB9ANPC1
SCHEMBL16990041 0.75 MAPT (0.51) MAPTGAAHPGDRAB9ANPC1
SCHEMBL16990045 0.72 GAA (0.61) MAPTGAAHPGDRAB9ANPC1
SCHEMBL6441776 0.72 MAPT (0.54) MAPTGAAHPGDRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042957-A1 Substituted Oxyarenes BAYER CROPSCIENCE AG (DE) 2009-02-12 US disclosed
CN-101128413-A Substituted oxyarenes BAYER CROPSCIENCE AG (DE) 2008-02-20 CN disclosed
EP-1831145-A1 SUBSTITUTED OXYARENES Bayer CropScience Aktiengesellschaft (DE) 2007-09-12 EP disclosed
WO-2006069685-A1 SUBSTITUTED OXYARENES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2006-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042957-A1 Substituted Oxyarenes CYP1A1, OXER1, CYP1A2 MAPT 3759/4885GAA 1847/4885HPGD 2640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.